By 
Are you at the cutting edge of medical innovation, harnessing the power of artificial intelligence to revolutionize patient care through image-guided therapies? If your answer is yes, then INOVAIT has an incredible opportunity waiting for you!
TORONTO — INOVAIT, Canada’s premier network dedicated to advancing image-guided therapy (IGT) and artificial intelligence (AI), is excited to announce its latest call for applications.
Today, we’re officially opening submissions for the Winter 2026 Pilot Fund. This isn’t just any funding program; it’s a vital non-dilutive initiative specifically designed to accelerate cutting-edge research and development (R&D) projects that bridge the gap between IGT and AI technologies.
The Pilot Fund offers crucial financial support without requiring equity or intellectual property dilution, allowing innovators to retain full ownership of their groundbreaking work. We’re seeking visionary projects that promise to transform diagnostics, enhance surgical precision, and improve patient outcomes across the healthcare spectrum.
This round of the Pilot Fund is poised to empower a new wave of advancements in medical technology. If your research or development project is pushing the boundaries in image-guided therapy with the integration of AI, we strongly encourage you to apply and become part of Canada’s vibrant innovation ecosystem.
Further details on eligibility, application requirements, and the specific funding available for this Winter 2026 Pilot Fund round will be made available on the INOVAIT website. Don’t miss this chance to turn your innovative ideas into impactful realities!
Source: Original Article
Comments